Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil.
Northwest Deanery, United Kingdom.
Nicholas
N
Truman
Daniel
D
Nethercott
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002430:Cecal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D010386:Pelvic Neoplasms / Q000188:drug therapy* / Q000556:secondary; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D011379:Prognosis
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005472:Fluorouracil